On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.8 which represents a decrease of $-0.22 or -3.13% from the prior close of $7.02. The stock opened at $7.05 and touched a low ...

Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...

MannKind Corp (MNKD) reports a 37% revenue increase, driven by Tyvaso DPI and Afrezza, while navigating market challenges and ...

Q3 2024 Earnings Call Transcript November 7, 2024 MannKind Corporation beats earnings expectations. Reported EPS is $0.05, ...

On Thursday, MannKind Corp (MNKD) stock saw a modest uptick, ending the day at $7.02 which represents a slight increase of $0.06 or 0.86% from the prior close of $6.96. The stock opened at $6.96 and ...

Shares of MannKind Co. (NASDAQ:MNKD – Get Free Report) have received a consensus recommendation of “Buy” from the seven ...

MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...

Westlake Village-based MannKind saw rising revenue and gave a positive update to its orphan lung pipeline when it announced its earnings for the third quarter of 2024. MannKind, a biotechnology ...

International Assets Investment Management LLC boosted its stake in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 511 ...

In a report released on November 7, Faisal Khurshid from Leerink Partners reiterated a Buy rating on MannKind (MNKD – Research Report), ...

Short MNKD slightly under 7.34, target 6.6, stop loss @ 7.36 Check the time stamp on this data. Updated AI-Generated Signals ...